SBI Securities
CRL icon

SBI Securities’s Charles River Laboratories CRL Stock Holding History

SBI Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Buy
153
+144
+1,600% +$25.6K ﹤0.01% 1313
2026
Q1 		$1.55K Hold
9
– – ﹤0.01% 2496
2025
Q4 		$1.8K Sell
9
-3
-25% -$544 ﹤0.01% 2431
2025
Q3 		$1.88K Buy
12
+5
+71% +$794 ﹤0.01% 2445
2025
Q2 		$1.06K Sell
7
-31
-82% -$4.13K ﹤0.01% 2655
2025
Q1 		$5.72K Buy
38
+7
+23% +$1.17K ﹤0.01% 1845
2024
Q4 		$5.72K Buy
+31
New +$5.97K ﹤0.01% 1881

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SBI Securities's CRL Position: Q2 2026 in Review

SBI Securities increased its Charles River Laboratories (CRL) stake by 1,600% in Q2 2026, buying an estimated $25.6K and bringing the position to 153 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

SBI Securities first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 571 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • SBI Securities held 153 shares of Charles River Laboratories worth $34.7K as of Q2 2026.
  • SBI Securities bought 144 Charles River Laboratories shares in Q2 2026, an estimated $25.6K.
  • Charles River Laboratories made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1313 holding.
  • SBI Securities first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 571 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.